An expert describes what an interventional clinical trial is.
William P. Harris, M.D., associate professor of Medical Oncology at the University of Washington Medical Center and associate member of the Clinical Research Division of the Fred Hutchinson Cancer Center, explains the basics of clinical trials.
Harris mainly works in interventional clinical trials, which compare a new drug or treatment (such as surgery or radiation) to current standard of care to see which one produces better outcomes.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More